| Entry |
|
|---|
| Name |
Insulin injection, biphasic isophane (BAN);
Biphasic isophane insuline human (genetical recombination) injectable aqueous suspension (JP18);
Insulin Humacart (TN) |
|---|
| Class |
Antidiabetic agent
DG01636 Insulin preparation
DG01802 Human insulin
Metabolizing enzyme inducer
DG01637 CYP1A2 inducer
|
|---|
| Remark |
| Therapeutic category: | 2492 |
|
|---|
| Efficacy |
Antidiabetic, Insulin receptor agonist |
|---|
| Comment |
Insulin with both rapid and intermediate action
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
CYP induction: CYP1A2 [HSA: 1544]
|
|---|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
24 Hormones
249 Miscellaneous
2492 Pancreatic hormones
D08080 Insulin injection, biphasic isophane (BAN); Biphasic isophane insuline human (genetical recombination) injectable aqueous suspension (JP18)
Drug groups [BR:br08330]
Antidiabetic agent
DG01636 Insulin preparation
DG01802 Human insulin
D08080 Insulin injection, biphasic isophane
Metabolizing enzyme inducer
DG01637 CYP1A2 inducer
D08080 Insulin injection, biphasic isophane
Drug classes [BR:br08332]
Antidiabetic agent
DG01636 Insulin preparation
D08080 Insulin injection, biphasic isophane
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
INSR family
INSR (CD220)
D08080 Insulin injection, biphasic isophane (BAN) <JP>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D08080 Biphasic isophane insuline human (genetical recombination) injectable aqueous suspension
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D08080
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
